| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Mar 25 | SEPN Septerna | Common Stock | Buy | Acquire P | No | No | 6.9277 | 13,319 | 92.27 k | 117,420 |
| 6 Mar 25 | SEPN Septerna | Common Stock | Buy | Acquire P | No | No | 6 | 41,355 | 248.13 k | 104,101 |
| 5 Mar 25 | SEPN Septerna | Common Stock | Buy | Acquire P | No | No | 5.8216 | 37,835 | 220.26 k | 62,746 |
| 4 Mar 25 | SEPN Septerna | Common Stock | Buy | Acquire P | No | No | 6.3468 | 7,491 | 47.54 k | 24,911 |
| 17 Jun 24 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7 | 30,000 | 210.00 k | 30,000 |
| 7 Jun 24 | OGN Organon & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 20.75 | 9,638.554 | 200.00 k | 36,454.814 |
